🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether the rituximab administrat...
Status
Completed
Location
Hospital Infanta Cristina
Start Date
2004-09
Trial ID
NCT01124526
Treatments Being Tested
RATIONALE: Pemetrexed disodium may stop the growth of tumor cells by blocki...
Status
Terminated
Location
University of Michigan Comprehensive Cancer Center
Start Date
2006-05
Trial ID
NCT00438204
Treatments Being Tested
The goal of this prospective study is to explore the safety and preliminary...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-01-15
Trial ID
NCT06775743
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
This is a study to look at whether the presence of circulating tumour DNA (...
Status
Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2022-03-28
Trial ID
NCT04966663
Treatments Being Tested
This is a prospective, multicentre, cohort study. For cohort 1(CGA cohort),...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-11
Trial ID
NCT06665087
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Status
Recruiting
Location
The fourth hospital of Hebei Medical University
Start Date
2024-11-15
Trial ID
NCT06576921
Treatments Being Tested
This phase 3 trial compares the addition of nivolumab to chemotherapy (carb...
Status
Active Not Recruiting
Location
Anchorage Associates in Radiation Medicine
Start Date
2020-11-17
Trial ID
NCT04444921
Treatments Being Tested
This trial is a Phase II study. All patients are resectable Gastric or Gast...
Status
Recruiting
Location
Tianjin Provincial Tumor Hospital
Start Date
2023-11-13
Trial ID
NCT05960955
Treatments Being Tested